PhRMA brings on board AstraZeneca exec for transition help
This article was originally published in Scrip
Executive Summary
The US pharmaceutical industry trade group, PhRMA, has announced that Chip Davis, vice-president of corporate external relations at AstraZeneca, will be joining the organisation to assist in a smooth transition as president and CEO Billy Tauzin prepares to leave his position on 30 June. Mr Tauzin's departure became known earlier this year (scripnews.com, 15 February 2010).